Synonyms: CDP 6038 | CDP-6038 | CDP6038
Compound class:
Antibody
Comment: Olokizumab (CDP 6038) is a clinical stage anti-IL-6 monoclonal antibody [3], that was designed for potential to treat autoimmune diseases. The antibody blocks assembly of the hexameric IL-6/IL-6 α-receptor/gp130 (IL6ST) complex that is required for signal transduction.
|
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
9333 | olokizumab |
Synonyms ![]() |
CDP 6038 | CDP-6038 | CDP6038 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 353 |
Other databases | |
GtoPdb PubChem SID | 442878635 |
Search PubMed clinical trials | olokizumab |
Search PubMed titles | olokizumab |
Search PubMed titles/abstracts | olokizumab |